Editor-in-Chief: Xiangdong Wang
Shanghai Institute of Clinical Bioinformatics
Journal list menu
Clinical and Translational Medicine is an open access journal accelerating the translation of preclinical research to a clinical application and the communication between basic and clinical scientists. We're proudly open access with a global audience of clinicians, researchers, and policy makers.
Why publish in Clinical and Translational Medicine?
- Enjoy a rapid turnaround time for submissions, with a first decision granted within an average of 8 days.
- Highly ranked in the fields of Research & Experimental Medicine and Oncology (SCI Index).
- Your work will be discoverable and widely distributed with indexing by MEDLINE, PubMed Central, SCIE, Web of Science and Directory of Open Access Journals.
- Your research will be open access, making it freely available to read, download and share with ease.
- Publish alongside quality and impactful research governed by a distinguished Editor-in-Chief and prestigious, international Editorial Board.
Clinical and Translational Medicine focuses on the bench to bedside approach, favoring studies and clinical observations which generate hypotheses and questions relevant to the patient and disease, and guide the investigations of cellular and molecular medicine.
Submissions from clinicians, researchers, policy makers, and industry are welcome.
Articles
Elucidating epigenetic landscape of gastric premalignant lesions through genome‐wide mapping of 5‐hydroxymethylcytosines: A 12‐year median follow‐up study
-  3 December 2024
Glucose‐induced LINC01419 reprograms the glycolytic pathway by recruiting YBX1 to enhance PDK1 mRNA stability in hepatocellular carcinoma
-  3 December 2024
Extracellular vesicles derived from creeping fat stem cells promote lymphatic function and restrain inflammation of Crohn's disease
-  2 December 2024
Graphical Abstract
1. Extracellular vesicles (EVs) derived from adipose tissue-derived stem cells in creeping fat (CrF) improve lymphatic functions and increase mesenteric lymphatic vessel density of Il-10-/– mice, leading to decreased colitis and mesenteritis through the miR-132-3p/RASA1 /ERK1/2 axis.
2. Co-culturing human lymphatic endothelial cells with CrF-EVs promotes proliferation, migration and tube function in vitro.
3. Upregulated miR-132-3p in CrF was negatively correlated with proinflammatory cytokines. Moreover, serum miR-132-3p was positively correlated with disease activity.
The role of the interplay between macrophage glycolytic reprogramming and NLRP3 inflammasome activation in acute lung injury/acute respiratory distress syndrome
-  2 December 2024
Graphical Abstract
Integration of single‐cell and bulk RNA sequencing unravels metalloendopeptidase+ neutrophils as key inflammatory drivers in abdominal aortic aneurysm
-  2 December 2024
Importance of integrating epidemiological and genomic surveillance of seasonal influenza viruses to monitor global circulation
-  2 December 2024
Spatial transcriptomics deciphers the immunosuppressive microenvironment in colorectal cancer with tumour thrombus
-  1 December 2024
A symbiotic mosquito‐gut bacterium for flavivirus control
-  29 November 2024
The gut microbiota‐derived metabolite indole‐3‐propionic acid enhances leptin sensitivity by targeting STAT3 against diet‐induced obesity
-  28 November 2024
Neutrophil, neutrophil extracellular traps and endothelial cell dysfunction in sepsis
- Clinical and Translational Medicine
-  11 January 2023
Graphical Abstract
1. Neutrophils show increased lifespan and impaired migration, both of which promote organ damage.
2. Neutrophils and neutrophil extracellular traps (NETs) induce pro-inflammatory and pro-angiogenic responses in endothelial cells.
3. Neutrophils and NETs degrade glycocalyx and increase endothelial permeability.
4. Neutrophils and NETs induce a pro-coagulant endothelial cell phenotype via degradation of the anti-coagulation system and up-regulation of tissue factors.
Multiplex immunofluorescence and single‐cell transcriptomic profiling reveal the spatial cell interaction networks in the non‐small cell lung cancer microenvironment
- Clinical and Translational Medicine
-  1 January 2023
Graphical Abstract
Exosome‐derived circTFDP2 promotes prostate cancer progression by preventing PARP1 from caspase‐3‐dependent cleavage
- Clinical and Translational Medicine
-  3 January 2023
Graphical Abstract
1. circTFDP2 is upregulated in prostate cancer tissues and positively correlated with the Gleason score, metastasis status and T stage of prostate cancer patients.
2. circTFDP2 promotes prostate cancer progression via directly binding to PARP1.
3. circTFDP2 could be secreted to the cell culture by exosomes.
The potential impact of ChatGPT in clinical and translational medicine
- Clinical and Translational Medicine
-  1 March 2023
Keeping an eye on circadian time in clinical research and medicine
- Clinical and Translational Medicine
-  25 December 2022
Graphical Abstract
Understanding the contribution of the endogenous circadian system to observed time-of-day rhythms can yield insights that further health-related research and optimize clinical treatments and increase life expectancy. This manuscript provides guidance on best practices in measuring and distinguishing endogenous circadian rhythms from time-of-day rhythms in a variety of settings.
Dissecting the role of cancer‐associated fibroblast‐derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single‐cell transcriptomic study
- Clinical and Translational Medicine
-  11 February 2023
Graphical Abstract
The opportunities and pitfalls of ChatGPT in clinical and translational medicine
- Clinical and Translational Medicine
-  28 February 2023
Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: Implications for prognosis and therapy prediction
- Clinical and Translational Medicine
-  18 January 2024
Geranylgeranyl diphosphate synthase: Role in human health, disease and potential therapeutic target
- Clinical and Translational Medicine
-  17 January 2023
Graphical Abstract
Initiative of clinical single‐cell biomedicine in clinical and translational medicine
- Clinical and Translational Medicine
-  11 January 2023
Neutrophil, neutrophil extracellular traps and endothelial cell dysfunction in sepsis
- Clinical and Translational Medicine
-  11 January 2023
Single-cell and spatial transcriptomics reveal POSTN+ cancer-associated fibroblasts correlated with immune suppression and tumour progression in non-small cell lung cancer
- Clinical and Translational Medicine
-  19 December 2023
mRNA vaccine in cancer therapy: Current advance and future outlook
- Clinical and Translational Medicine
-  23 August 2023
The molecular classification of cancer‐associated fibroblasts on a pan‐cancer single‐cell transcriptional atlas
- Clinical and Translational Medicine
-  26 December 2023
METTL3‐mediated N6‐methyladenosine exacerbates ferroptosis via m6A‐IGF2BP2‐dependent mitochondrial metabolic reprogramming in sepsis‐induced acute lung injury
- Clinical and Translational Medicine
-  15 September 2023
Multiplex immunofluorescence and single‐cell transcriptomic profiling reveal the spatial cell interaction networks in the non‐small cell lung cancer microenvironment
- Clinical and Translational Medicine
-  1 January 2023
Single‐cell transcriptome sequencing of B‐cell heterogeneity and tertiary lymphoid structure predicts breast cancer prognosis and neoadjuvant therapy efficacy
- Clinical and Translational Medicine
-  1 August 2023
H. pylori-induced NF-κB-PIEZO1-YAP1-CTGF axis drives gastric cancer progression and cancer-associated fibroblast-mediated tumour microenvironment remodelling
- Clinical and Translational Medicine
-  20 November 2023
Spatiotemporally deciphering the mysterious mechanism of persistent HPV‐induced malignant transition and immune remodelling from HPV‐infected normal cervix, precancer to cervical cancer: Integrating single‐cell RNA‐sequencing and spatial transcriptome
- Clinical and Translational Medicine
-  26 March 2023
Integrated single‐cell and spatial transcriptomic profiling reveals higher intratumour heterogeneity and epithelial–fibroblast interactions in recurrent bladder cancer
- Clinical and Translational Medicine
-  24 July 2023
Recent issues
- Volume 14, Issue 12December 2024
- Volume 14, Issue 11November 2024
- Volume 14, Issue 10October 2024
- Volume 14, Issue 9September 2024